CORVUS PHARMACEUTICALS ANNOUNCES INITIAL DATA FROM SOQUELITINIB CLINICAL TRIAL IN PATIENTS WITH AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS) WILL BE PRESENTED AT THE 68ᵗʰ AMERICAN SOCIETY FOR HEMATOLOGY ANNUAL MEETING & EXPOSITION

Reuters · 18h ago

Please log in to view news